APO Research
Talk to an analyst

APO RESEARCH · REPORT

1,5-Diazabicyclo[4.3.0]non-5-ene

1,5-Diazabicyclo[4.3.0]non-5-ene is a bicyclic nitrogen-containing organic compound.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Chemical identity, substitution pattern, assay and related impurities define the supplied material. The named chemical category does not establish a finished formulation’s compatibility, end-use approval or performance; those depend on the actual grade and application.

The commercial boundary

Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.

Which supplied interfaces and acceptance criteria define 1,5-Diazabicyclo[4.3.0]non-5-ene?

Chemical identity, substitution pattern, assay and related impurities define the supplied material. The named chemical category does not establish a finished formulation’s compatibility, end-use approval or performance; those depend on the actual grade and application.

Selected research

Market Analysis & Forecast

Global 1,5-Diazabicyclo[4.3.0]non-5-ene Market Analysis and Forecast 2026-2032

21 December 2025218 pages

Choose your research edition.

Industry Research1,5-Diazabicyclo[4.3.0]non-5-ene Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal 1,5-Diazabicyclo[4.3.0]non-5-ene Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal 1,5-Diazabicyclo[4.3.0]non-5-ene Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 1,5-Diazabicyclo[4.3.0]non-5-ene Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal 1,5-Diazabicyclo[4.3.0]non-5-ene Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global 1,5-Diazabicyclo[4.3.0]non-5-ene market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

1,5-Diazabicyclo[4.3.0]non-5-ene's global sales reached XX (Ton) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Chemical Point as the global sales leader, a title it has maintained for several consecutive years. Notably, Chemical Point's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Ton), a change of XX% from the previous year. In Europe, sales were XX (Ton), showing a year-on-year of XX%. In the US, sales were XX (Ton), a year-on-year change of XX%.

The major global manufacturers in the 1,5-Diazabicyclo[4.3.0]non-5-ene market include Chemical Point, Crescent Chemical, Scandinavian Formulas, Simagchem, Tetrahedron Scientific, Waterstone Tech, Victory Chemical, Kemi-works Chemical and Junwee, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the 1,5-Diazabicyclo[4.3.0]non-5-ene production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of 1,5-Diazabicyclo[4.3.0]non-5-ene by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for 1,5-Diazabicyclo[4.3.0]non-5-ene, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of 1,5-Diazabicyclo[4.3.0]non-5-ene, also provides the consumption of main regions and countries. Of the upcoming market potential for 1,5-Diazabicyclo[4.3.0]non-5-ene, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the 1,5-Diazabicyclo[4.3.0]non-5-ene sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global 1,5-Diazabicyclo[4.3.0]non-5-ene market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for 1,5-Diazabicyclo[4.3.0]non-5-ene sales, projected growth trends, production technology, application and end-user industry.

1,5-Diazabicyclo[4.3.0]non-5-ene Segment by Company

Chemical Point

Crescent Chemical

Scandinavian Formulas

Simagchem

Tetrahedron Scientific

Waterstone Tech

Victory Chemical

Kemi-works Chemical

Junwee

Hongrun

Chuanghai Biotech

Beyond Industries (China)

Junsei Chemical

2A Pharmachem

1,5-Diazabicyclo[4.3.0]non-5-ene Segment by Type

Purity Above 98%

Purity Below 98%

1,5-Diazabicyclo[4.3.0]non-5-ene Segment by Application

Resin Curing Agent

Polyurethane Catalyst

Others

1,5-Diazabicyclo[4.3.0]non-5-ene Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 1,5-Diazabicyclo[4.3.0]non-5-ene market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 1,5-Diazabicyclo[4.3.0]non-5-ene and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 1,5-Diazabicyclo[4.3.0]non-5-ene.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: 1,5-Diazabicyclo[4.3.0]non-5-ene production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of 1,5-Diazabicyclo[4.3.0]non-5-ene in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of 1,5-Diazabicyclo[4.3.0]non-5-ene manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, 1,5-Diazabicyclo[4.3.0]non-5-ene sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Purity Above 98% Major Manufacturers Table 3. Purity Below 98% Major Manufacturers Table 4. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Resin Curing Agent Major Manufacturers Table 6. Polyurethane Catalyst Major Manufacturers Table 7. Others Major Manufacturers Table 8. 1,5-Diazabicyclo[4.3.0]non-5-ene Industry Trends Table 9. 1,5-Diazabicyclo[4.3.0]non-5-ene Industry Drivers Table 10. 1,5-Diazabicyclo[4.3.0]non-5-ene Industry Opportunities and Challenges Table 11. 1,5-Diazabicyclo[4.3.0]non-5-ene Industry Restraints Table 12. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Ton) Table 13. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Production by Region (2021-2026) & (Ton) Table 14. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Production by Region (2027-2032) & (Ton) Table 15. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Production Market Share by Region (2021-2026) Table 16. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Production Market Share by Region (2027-2032) Table 17. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Region (2021-2026) & (US$ Million) Table 19. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Region (2027-2032) & (US$ Million) Table 20. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Market Share by Region (2021-2026) Table 21. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Market Share by Region (2027-2032) Table 22. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Ton) Table 23. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Region (2021-2026) & (Ton) Table 24. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Region (2027-2032) & (Ton) Table 25. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Market Share by Region (2021-2026) Table 26. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Market Share by Region (2027-2032) Table 27. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Market Share by Manufacturers (2021-2026) Table 29. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Market Share by Manufacturers (2021-2026) Table 31. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 32. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Manufacturers, Product Type & Application Table 35. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Manufacturers Commercialization Time Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global 1,5-Diazabicyclo[4.3.0]non-5-ene by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 38. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2021-2026) & (US$ Million) Table 39. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2027-2032) & (US$ Million) Table 40. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Market Share by Type (2021-2026) Table 41. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Market Share by Type (2027-2032) Table 42. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2021-2026) & (Ton) Table 43. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2027-2032) & (Ton) Table 44. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Market Share by Type (2021-2026) Table 45. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Market Share by Type (2027-2032) Table 46. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Type (2021-2026) & (US$/Ton) Table 47. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Type (2027-2032) & (US$/Ton) Table 48. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2021-2026) & (US$ Million) Table 49. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2027-2032) & (US$ Million) Table 50. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Market Share by Application (2021-2026) Table 51. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Market Share by Application (2027-2032) Table 52. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2021-2026) & (Ton) Table 53. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2027-2032) & (Ton) Table 54. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Market Share by Application (2021-2026) Table 55. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Market Share by Application (2027-2032) Table 56. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Application (2021-2026) & (US$/Ton) Table 57. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Application (2027-2032) & (US$/Ton) Table 58. Chemical Point Company Information Table 59. Chemical Point Business Overview Table 60. Chemical Point 1,5-Diazabicyclo[4.3.0]non-5-ene Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Chemical Point 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio Table 62. Chemical Point Recent Development Table 63. Crescent Chemical Company Information Table 64. Crescent Chemical Business Overview Table 65. Crescent Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Crescent Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio Table 67. Crescent Chemical Recent Development Table 68. Scandinavian Formulas Company Information Table 69. Scandinavian Formulas Business Overview Table 70. Scandinavian Formulas 1,5-Diazabicyclo[4.3.0]non-5-ene Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Scandinavian Formulas 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio Table 72. Scandinavian Formulas Recent Development Table 73. Simagchem Company Information Table 74. Simagchem Business Overview Table 75. Simagchem 1,5-Diazabicyclo[4.3.0]non-5-ene Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Simagchem 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio Table 77. Simagchem Recent Development Table 78. Tetrahedron Scientific Company Information Table 79. Tetrahedron Scientific Business Overview Table 80. Tetrahedron Scientific 1,5-Diazabicyclo[4.3.0]non-5-ene Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Tetrahedron Scientific 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio Table 82. Tetrahedron Scientific Recent Development Table 83. Waterstone Tech Company Information Table 84. Waterstone Tech Business Overview Table 85. Waterstone Tech 1,5-Diazabicyclo[4.3.0]non-5-ene Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Waterstone Tech 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio Table 87. Waterstone Tech Recent Development Table 88. Victory Chemical Company Information Table 89. Victory Chemical Business Overview Table 90. Victory Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Victory Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio Table 92. Victory Chemical Recent Development Table 93. Kemi-works Chemical Company Information Table 94. Kemi-works Chemical Business Overview Table 95. Kemi-works Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Kemi-works Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio Table 97. Kemi-works Chemical Recent Development Table 98. Junwee Company Information Table 99. Junwee Business Overview Table 100. Junwee 1,5-Diazabicyclo[4.3.0]non-5-ene Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Junwee 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio Table 102. Junwee Recent Development Table 103. Hongrun Company Information Table 104. Hongrun Business Overview Table 105. Hongrun 1,5-Diazabicyclo[4.3.0]non-5-ene Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Hongrun 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio Table 107. Hongrun Recent Development Table 108. Chuanghai Biotech Company Information Table 109. Chuanghai Biotech Business Overview Table 110. Chuanghai Biotech 1,5-Diazabicyclo[4.3.0]non-5-ene Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Chuanghai Biotech 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio Table 112. Chuanghai Biotech Recent Development Table 113. Beyond Industries (China) Company Information Table 114. Beyond Industries (China) Business Overview Table 115. Beyond Industries (China) 1,5-Diazabicyclo[4.3.0]non-5-ene Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Beyond Industries (China) 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio Table 117. Beyond Industries (China) Recent Development Table 118. Junsei Chemical Company Information Table 119. Junsei Chemical Business Overview Table 120. Junsei Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Junsei Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio Table 122. Junsei Chemical Recent Development Table 123. 2A Pharmachem Company Information Table 124. 2A Pharmachem Business Overview Table 125. 2A Pharmachem 1,5-Diazabicyclo[4.3.0]non-5-ene Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. 2A Pharmachem 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio Table 127. 2A Pharmachem Recent Development Table 128. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2021-2026) & (US$ Million) Table 129. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2027-2032) & (US$ Million) Table 130. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2021-2026) & (Ton) Table 131. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2027-2032) & (Ton) Table 132. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Type (2021-2026) & (US$/Ton) Table 133. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Type (2027-2032) & (US$/Ton) Table 134. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2021-2026) & (US$ Million) Table 135. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2027-2032) & (US$ Million) Table 136. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2021-2026) & (Ton) Table 137. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2027-2032) & (Ton) Table 138. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Application (2021-2026) & (US$/Ton) Table 139. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Application (2027-2032) & (US$/Ton) Table 140. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2021 VS 2025 VS 2032) & (Ton) Table 144. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2021-2026) & (Ton) Table 145. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2027-2032) & (Ton) Table 146. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Country (2021-2026) & (US$/Ton) Table 147. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Country (2027-2032) & (US$/Ton) Table 148. United States 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 149. Canada 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 150. Mexico 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 151. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2021-2026) & (US$ Million) Table 152. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2027-2032) & (US$ Million) Table 153. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2021-2026) & (Ton) Table 154. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2027-2032) & (Ton) Table 155. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Type (2021-2026) & (US$/Ton) Table 156. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Type (2027-2032) & (US$/Ton) Table 157. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2021-2026) & (US$ Million) Table 158. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2027-2032) & (US$ Million) Table 159. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2021-2026) & (Ton) Table 160. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2027-2032) & (Ton) Table 161. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Application (2021-2026) & (US$/Ton) Table 162. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Application (2027-2032) & (US$/Ton) Table 163. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2021 VS 2025 VS 2032) & (Ton) Table 167. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2021-2026) & (Ton) Table 168. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2027-2032) & (Ton) Table 169. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Country (2021-2026) & (US$/Ton) Table 170. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Country (2027-2032) & (US$/Ton) Table 171. Germany 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 172. France 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 173. U.K. 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 174. Italy 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 175. Russia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 176. Spain 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 177. Netherlands 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 178. Switzerland 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 179. Sweden 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 180. Poland 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 181. China 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2021-2026) & (US$ Million) Table 182. China 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2027-2032) & (US$ Million) Table 183. China 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2021-2026) & (Ton) Table 184. China 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2027-2032) & (Ton) Table 185. China 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Type (2021-2026) & (US$/Ton) Table 186. China 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Type (2027-2032) & (US$/Ton) Table 187. China 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2021-2026) & (US$ Million) Table 188. China 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2027-2032) & (US$ Million) Table 189. China 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2021-2026) & (Ton) Table 190. China 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2027-2032) & (Ton) Table 191. China 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Application (2021-2026) & (US$/Ton) Table 192. China 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Application (2027-2032) & (US$/Ton) Table 193. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2021-2026) & (US$ Million) Table 194. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2027-2032) & (US$ Million) Table 195. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2021-2026) & (Ton) Table 196. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2027-2032) & (Ton) Table 197. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Type (2021-2026) & (US$/Ton) Table 198. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Type (2027-2032) & (US$/Ton) Table 199. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2021-2026) & (US$ Million) Table 200. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2027-2032) & (US$ Million) Table 201. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2021-2026) & (Ton) Table 202. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2027-2032) & (Ton) Table 203. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Application (2021-2026) & (US$/Ton) Table 204. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Application (2027-2032) & (US$/Ton) Table 205. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2021 VS 2025 VS 2032) & (Ton) Table 209. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2021-2026) & (Ton) Table 210. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2027-2032) & (Ton) Table 211. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Country (2021-2026) & (US$/Ton) Table 212. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Country (2027-2032) & (US$/Ton) Table 213. Japan 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 214. South Korea 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 215. India 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 216. Australia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 217. Taiwan 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 218. Southeast Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 219. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2021-2026) & (US$ Million) Table 220. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2027-2032) & (US$ Million) Table 221. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2021-2026) & (Ton) Table 222. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2027-2032) & (Ton) Table 223. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Type (2021-2026) & (US$/Ton) Table 224. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Type (2027-2032) & (US$/Ton) Table 225. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2021-2026) & (US$ Million) Table 226. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2027-2032) & (US$ Million) Table 227. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2021-2026) & (Ton) Table 228. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2027-2032) & (Ton) Table 229. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Application (2021-2026) & (US$/Ton) Table 230. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Application (2027-2032) & (US$/Ton) Table 231. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 232. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 233. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 234. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2021 VS 2025 VS 2032) & (Ton) Table 235. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2021-2026) & (Ton) Table 236. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2027-2032) & (Ton) Table 237. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Country (2021-2026) & (US$/Ton) Table 238. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Country (2027-2032) & (US$/Ton) Table 239. Brazil 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 240. Argentina 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 241. Chile 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 242. Colombia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 243. Peru 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 244. Saudi Arabia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 245. Israel 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 246. UAE 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 247. Turkey 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 248. Iran 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 249. Egypt 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Table 250. Key Raw Materials Table 251. Raw Materials Key Suppliers Table 252. 1,5-Diazabicyclo[4.3.0]non-5-ene Distributors List Table 253. 1,5-Diazabicyclo[4.3.0]non-5-ene Customers List Table 254. Research Programs/Design for This Report Table 255. Authors List of This Report Table 256. Secondary Sources Table 257. Primary Sources List of Figures Figure 1. 1,5-Diazabicyclo[4.3.0]non-5-ene Product Image Figure 2. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size Share 2021 VS 2025 VS 2032 Figure . Purity Above 98% Image Figure 1. Purity Below 98% Image Figure 2. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size Share 2021 VS 2025 VS 2032 Figure 4. Resin Curing Agent Image Figure 5. Polyurethane Catalyst Image Figure 6. Others Image Figure 7. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Capacity, Capacity Utilization (2021-2032) & (Ton) Figure 8. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Production by Region: 2021 VS 2025 VS 2032 (Ton) Figure 9. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Production Market Share by Region: 2025 Versus 2032 Figure 10. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Production Market Share by Region (2021-2032) Figure 11. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Production Growth Rate (2021-2032) & (Ton) Figure 12. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Production Growth Rate (2021-2032) & (Ton) Figure 13. China 1,5-Diazabicyclo[4.3.0]non-5-ene Production Growth Rate (2021-2032) & (Ton) Figure 14. Japan 1,5-Diazabicyclo[4.3.0]non-5-ene Production Growth Rate (2021-2032) & (Ton) Figure 15. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (2021-2032) & (US$ Million) Figure 17. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Market Share by Region (2021-2032) Figure 20. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales (2021-2032) & (Ton) Figure 21. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Region: 2021 VS 2025 VS 2032 (Ton) Figure 22. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Market Share by Region (2021-2032) Figure 23. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales YoY (2021-2032) & (Ton) Figure 24. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales YoY (2021-2032) & (Ton) Figure 25. China 1,5-Diazabicyclo[4.3.0]non-5-ene Sales YoY (2021-2032) & (Ton) Figure 26. Asia (Excluding China) 1,5-Diazabicyclo[4.3.0]non-5-ene Sales YoY (2021-2032) & (Ton) Figure 27. South America, Middle East and Africa 1,5-Diazabicyclo[4.3.0]non-5-ene Sales YoY (2021-2032) & (Ton) Figure 28. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Market Share by Type (2021-2032) Figure 32. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Market Share by Type (2021-2032) Figure 33. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Market Share by Application (2021-2032) Figure 34. Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Market Share by Application (2021-2032) Figure 35. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Share by Type (2021-2032) Figure 36. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Share by Type (2021-2032) Figure 37. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Share by Application (2021-2032) Figure 38. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Share by Application (2021-2032) Figure 39. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Share by Country (2021-2032) Figure 40. North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Share by Country (2021-2032) Figure 41. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Share by Type (2021-2032) Figure 42. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Share by Type (2021-2032) Figure 43. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Share by Application (2021-2032) Figure 44. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Share by Application (2021-2032) Figure 45. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Share by Country (2021-2032) Figure 46. Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Share by Country (2021-2032) Figure 47. China 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Share by Type (2021-2032) Figure 48. China 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Share by Type (2021-2032) Figure 49. China 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Share by Application (2021-2032) Figure 50. China 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Share by Application (2021-2032) Figure 51. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Share by Type (2021-2032) Figure 52. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Share by Type (2021-2032) Figure 53. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Share by Application (2021-2032) Figure 54. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Share by Application (2021-2032) Figure 55. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Share by Country (2021-2032) Figure 56. Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Share by Country (2021-2032) Figure 57. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Share by Type (2021-2032) Figure 58. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Share by Type (2021-2032) Figure 59. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Share by Application (2021-2032) Figure 60. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Share by Application (2021-2032) Figure 61. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Share by Country (2021-2032) Figure 62. SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Share by Country (2021-2032) Figure 63. 1,5-Diazabicyclo[4.3.0]non-5-ene Value Chain Figure 64. Manufacturing Cost Structure Figure 65. 1,5-Diazabicyclo[4.3.0]non-5-ene Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Purity Above 98%
  • Purity Below 98%
Applications
  • Resin Curing Agent
  • Polyurethane Catalyst
  • Others
Companies covered
  • Chemical Point
  • Crescent Chemical
  • Scandinavian Formulas
  • Simagchem
  • Tetrahedron Scientific
  • Waterstone Tech
  • Victory Chemical
  • Kemi-works Chemical
  • Junwee
  • Hongrun
  • Chuanghai Biotech
  • Beyond Industries (China)
  • Junsei Chemical
  • 2A Pharmachem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 1,5-Diazabicyclo[4.3.0]non-5-ene Market by Type
  3. 1.2.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Purity Above 98%
  5. 1.2.3 Purity Below 98%
  6. 1.3 1,5-Diazabicyclo[4.3.0]non-5-ene Market by Application
  7. 1.3.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Resin Curing Agent
  9. 1.3.3 Polyurethane Catalyst
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 1,5-Diazabicyclo[4.3.0]non-5-ene Market Dynamics
  1. 2.1 1,5-Diazabicyclo[4.3.0]non-5-ene Industry Trends
  2. 2.2 1,5-Diazabicyclo[4.3.0]non-5-ene Industry Drivers
  3. 2.3 1,5-Diazabicyclo[4.3.0]non-5-ene Industry Opportunities and Challenges
  4. 2.4 1,5-Diazabicyclo[4.3.0]non-5-ene Industry Restraints
3 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Production Overview
  1. 3.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Production Capacity (2021-2032)
  2. 3.2 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Production by Region
  4. 3.3.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Production by Region (2021-2026)
  5. 3.3.2 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Production by Region (2027-2032)
  6. 3.3.3 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Region
  3. 4.2.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Region (2021-2026)
  5. 4.2.3 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Region (2027-2032)
  6. 4.2.4 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Market Share by Region (2021-2032)
  7. 4.3 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Region
  9. 4.4.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Region (2021-2026)
  11. 4.4.3 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Region (2027-2032)
  12. 4.4.4 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Manufacturers
  2. 5.1.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Manufacturers
  6. 5.2.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Manufacturers, Product Type & Application
  13. 5.7 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Market CR5 and HHI
  16. 5.8.2 2025 1,5-Diazabicyclo[4.3.0]non-5-ene Tier 1, Tier 2, and Tier 3
6 1,5-Diazabicyclo[4.3.0]non-5-ene Market by Type
  1. 6.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type
  2. 6.1.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Market Share by Type (2021-2032)
  4. 6.2 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type
  5. 6.2.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2021-2032) & (Ton)
  6. 6.2.2 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Market Share by Type (2021-2032)
  7. 6.3 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Type
7 1,5-Diazabicyclo[4.3.0]non-5-ene Market by Application
  1. 7.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application
  2. 7.1.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Market Share by Application (2021-2032)
  4. 7.2 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application
  5. 7.2.1 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2021-2032) & (Ton)
  6. 7.2.2 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Market Share by Application (2021-2032)
  7. 7.3 Global 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Application
8 Company Profiles
  1. 8.1 Chemical Point
  2. 8.1.1 Chemical Point Company Information
  3. 8.1.2 Chemical Point Business Overview
  4. 8.1.3 Chemical Point 1,5-Diazabicyclo[4.3.0]non-5-ene Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Chemical Point 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio
  6. 8.1.5 Chemical Point Recent Developments
  7. 8.2 Crescent Chemical
  8. 8.2.1 Crescent Chemical Company Information
  9. 8.2.2 Crescent Chemical Business Overview
  10. 8.2.3 Crescent Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Crescent Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio
  12. 8.2.5 Crescent Chemical Recent Developments
  13. 8.3 Scandinavian Formulas
  14. 8.3.1 Scandinavian Formulas Company Information
  15. 8.3.2 Scandinavian Formulas Business Overview
  16. 8.3.3 Scandinavian Formulas 1,5-Diazabicyclo[4.3.0]non-5-ene Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Scandinavian Formulas 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio
  18. 8.3.5 Scandinavian Formulas Recent Developments
  19. 8.4 Simagchem
  20. 8.4.1 Simagchem Company Information
  21. 8.4.2 Simagchem Business Overview
  22. 8.4.3 Simagchem 1,5-Diazabicyclo[4.3.0]non-5-ene Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Simagchem 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio
  24. 8.4.5 Simagchem Recent Developments
  25. 8.5 Tetrahedron Scientific
  26. 8.5.1 Tetrahedron Scientific Company Information
  27. 8.5.2 Tetrahedron Scientific Business Overview
  28. 8.5.3 Tetrahedron Scientific 1,5-Diazabicyclo[4.3.0]non-5-ene Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Tetrahedron Scientific 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio
  30. 8.5.5 Tetrahedron Scientific Recent Developments
  31. 8.6 Waterstone Tech
  32. 8.6.1 Waterstone Tech Company Information
  33. 8.6.2 Waterstone Tech Business Overview
  34. 8.6.3 Waterstone Tech 1,5-Diazabicyclo[4.3.0]non-5-ene Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Waterstone Tech 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio
  36. 8.6.5 Waterstone Tech Recent Developments
  37. 8.7 Victory Chemical
  38. 8.7.1 Victory Chemical Company Information
  39. 8.7.2 Victory Chemical Business Overview
  40. 8.7.3 Victory Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Victory Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio
  42. 8.7.5 Victory Chemical Recent Developments
  43. 8.8 Kemi-works Chemical
  44. 8.8.1 Kemi-works Chemical Company Information
  45. 8.8.2 Kemi-works Chemical Business Overview
  46. 8.8.3 Kemi-works Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 Kemi-works Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio
  48. 8.8.5 Kemi-works Chemical Recent Developments
  49. 8.9 Junwee
  50. 8.9.1 Junwee Company Information
  51. 8.9.2 Junwee Business Overview
  52. 8.9.3 Junwee 1,5-Diazabicyclo[4.3.0]non-5-ene Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Junwee 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio
  54. 8.9.5 Junwee Recent Developments
  55. 8.10 Hongrun
  56. 8.10.1 Hongrun Company Information
  57. 8.10.2 Hongrun Business Overview
  58. 8.10.3 Hongrun 1,5-Diazabicyclo[4.3.0]non-5-ene Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Hongrun 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio
  60. 8.10.5 Hongrun Recent Developments
  61. 8.11 Chuanghai Biotech
  62. 8.11.1 Chuanghai Biotech Company Information
  63. 8.11.2 Chuanghai Biotech Business Overview
  64. 8.11.3 Chuanghai Biotech 1,5-Diazabicyclo[4.3.0]non-5-ene Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 8.11.4 Chuanghai Biotech 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio
  66. 8.11.5 Chuanghai Biotech Recent Developments
  67. 8.12 Beyond Industries (China)
  68. 8.12.1 Beyond Industries (China) Company Information
  69. 8.12.2 Beyond Industries (China) Business Overview
  70. 8.12.3 Beyond Industries (China) 1,5-Diazabicyclo[4.3.0]non-5-ene Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 8.12.4 Beyond Industries (China) 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio
  72. 8.12.5 Beyond Industries (China) Recent Developments
  73. 8.13 Junsei Chemical
  74. 8.13.1 Junsei Chemical Company Information
  75. 8.13.2 Junsei Chemical Business Overview
  76. 8.13.3 Junsei Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 8.13.4 Junsei Chemical 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio
  78. 8.13.5 Junsei Chemical Recent Developments
  79. 8.14 2A Pharmachem
  80. 8.14.1 2A Pharmachem Company Information
  81. 8.14.2 2A Pharmachem Business Overview
  82. 8.14.3 2A Pharmachem 1,5-Diazabicyclo[4.3.0]non-5-ene Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 8.14.4 2A Pharmachem 1,5-Diazabicyclo[4.3.0]non-5-ene Product Portfolio
  84. 8.14.5 2A Pharmachem Recent Developments
9 North America
  1. 9.1 North America 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Type
  2. 9.1.1 North America 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2021-2032)
  3. 9.1.2 North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2021-2032)
  4. 9.1.3 North America 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Type (2021-2032)
  5. 9.2 North America 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Application
  6. 9.2.1 North America 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2021-2032)
  7. 9.2.2 North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2021-2032)
  8. 9.2.3 North America 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Application (2021-2032)
  9. 9.3 North America 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Country
  10. 9.3.1 North America 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Type
  2. 10.1.1 Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2021-2032)
  3. 10.1.2 Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2021-2032)
  4. 10.1.3 Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Type (2021-2032)
  5. 10.2 Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Application
  6. 10.2.1 Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2021-2032)
  7. 10.2.2 Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2021-2032)
  8. 10.2.3 Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Application (2021-2032)
  9. 10.3 Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Country
  10. 10.3.1 Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Type
  2. 11.1.1 China 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2021-2032)
  3. 11.1.2 China 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2021-2032)
  4. 11.1.3 China 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Type (2021-2032)
  5. 11.2 China 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Application
  6. 11.2.1 China 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2021-2032)
  7. 11.2.2 China 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2021-2032)
  8. 11.2.3 China 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Type
  2. 12.1.1 Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2021-2032)
  3. 12.1.2 Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2021-2032)
  4. 12.1.3 Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Type (2021-2032)
  5. 12.2 Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Application
  6. 12.2.1 Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2021-2032)
  7. 12.2.2 Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2021-2032)
  8. 12.2.3 Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Application (2021-2032)
  9. 12.3 Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Country
  10. 12.3.1 Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Type
  2. 13.1.1 SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Type (2021-2032)
  4. 13.1.3 SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Type (2021-2032)
  5. 13.2 SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Application
  6. 13.2.1 SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Application (2021-2032)
  8. 13.2.3 SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Application (2021-2032)
  9. 13.3 SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Market Size by Country
  10. 13.3.1 SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA 1,5-Diazabicyclo[4.3.0]non-5-ene Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 1,5-Diazabicyclo[4.3.0]non-5-ene Value Chain Analysis
  2. 14.1.1 1,5-Diazabicyclo[4.3.0]non-5-ene Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 1,5-Diazabicyclo[4.3.0]non-5-ene Production Mode & Process
  6. 14.2 1,5-Diazabicyclo[4.3.0]non-5-ene Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 1,5-Diazabicyclo[4.3.0]non-5-ene Distributors
  9. 14.2.3 1,5-Diazabicyclo[4.3.0]non-5-ene Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst